Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea · Delayed Price · Currency is KRW 4,855.00
-155.00 (-3.09%)
At close: Feb 27, 2026
Aligned Genetics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 3,743 | 4,128 | 3,236 | 2,333 | 5,542 | 468.23 |
Depreciation & Amortization | 558.59 | 575.74 | 631.38 | 650.38 | 538.59 | 676.07 |
Loss (Gain) From Sale of Assets | 0 | - | -4.5 | - | -13.94 | - |
Loss (Gain) From Sale of Investments | 302.16 | 7.44 | -34.04 | 591.23 | -1,686 | -944.36 |
Loss (Gain) on Equity Investments | -0 | 29.26 | 181.79 | -80.52 | 178.96 | 79.28 |
Provision & Write-off of Bad Debts | 7.78 | -2.79 | -0.55 | -11.88 | 2.97 | 20.04 |
Other Operating Activities | -572.24 | -739.87 | 487.38 | 417.53 | 99.1 | 683.89 |
Change in Accounts Receivable | -672.1 | 82.54 | -1,214 | 717.6 | -2,025 | -371.67 |
Change in Inventory | -88.89 | -119.94 | -55.66 | -1,407 | -337.39 | -101.87 |
Change in Accounts Payable | -41.61 | -219.98 | 14.31 | -53.19 | 1,017 | 161.57 |
Change in Unearned Revenue | -9.06 | -18.91 | 9.86 | - | - | - |
Change in Other Net Operating Assets | -2,630 | -699.56 | -452.6 | -1,084 | -1,409 | -635.5 |
Operating Cash Flow | 594.19 | 3,065 | 2,849 | 2,222 | 135.97 | 35.67 |
Operating Cash Flow Growth | -77.61% | 7.61% | 28.18% | 1534.52% | 281.17% | -94.59% |
Capital Expenditures | -461.57 | -257.69 | -878.54 | -2,001 | -3,307 | -96.43 |
Sale of Property, Plant & Equipment | - | - | 12.98 | - | 32.25 | - |
Sale (Purchase) of Intangibles | -117.48 | -145.75 | -1.87 | -2.23 | - | -9.07 |
Sale (Purchase) of Real Estate | - | - | - | - | -1,557 | - |
Investment in Securities | -862.78 | -7,011 | 1,502 | 4,000 | 248.18 | 699.95 |
Other Investing Activities | 824.2 | 282.35 | 655.49 | 555.69 | 916.01 | 571.46 |
Investing Cash Flow | -400.42 | -7,545 | 1,290 | 2,537 | -3,668 | 1,166 |
Short-Term Debt Issued | - | - | - | - | 978 | - |
Long-Term Debt Issued | - | 2,400 | - | - | 3,900 | - |
Total Debt Issued | - | 2,400 | - | - | 4,878 | - |
Short-Term Debt Repaid | - | - | - | - | -978 | - |
Long-Term Debt Repaid | - | -4,130 | -192.75 | -176.33 | -267.41 | -227.56 |
Total Debt Repaid | -230.12 | -4,130 | -192.75 | -176.33 | -1,245 | -227.56 |
Net Debt Issued (Repaid) | -230.12 | -1,730 | -192.75 | -176.33 | 3,633 | -227.56 |
Financing Cash Flow | -1,228 | -1,730 | -192.75 | -176.33 | 3,633 | -227.56 |
Foreign Exchange Rate Adjustments | 727.09 | 1,422 | 284.86 | -24.31 | 397.42 | -233.22 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | 0 |
Net Cash Flow | -306.8 | -4,788 | 4,231 | 4,559 | 498.31 | 740.79 |
Free Cash Flow | 132.61 | 2,808 | 1,970 | 220.98 | -3,171 | -60.76 |
Free Cash Flow Growth | -94.62% | 42.52% | 791.50% | - | - | - |
Free Cash Flow Margin | 0.76% | 17.79% | 12.95% | 1.61% | -26.96% | -0.76% |
Free Cash Flow Per Share | 9.34 | 195.26 | 137.01 | 15.37 | -220.57 | -5.84 |
Cash Interest Paid | 82.5 | 138.56 | 190.05 | 165.3 | 28.88 | 82.9 |
Cash Income Tax Paid | 121.79 | 122.89 | 169 | 49.25 | 113.39 | 8.65 |
Levered Free Cash Flow | -560.21 | 1,112 | 947.12 | -388.58 | -2,676 | 345.83 |
Unlevered Free Cash Flow | -519.19 | 1,217 | 1,081 | -284.86 | -2,658 | 397.6 |
Change in Working Capital | -3,445 | -932.52 | -1,649 | -1,677 | -4,526 | -947.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.